Literature DB >> 2297695

31P magnetic resonance spectroscopy of human colon cancer.

J N Kasimos1, T E Merchant, L W Gierke, T Glonek.   

Abstract

Phosphatic metabolite profiles of 19 malignant and normal human colon specimens were analyzed by techniques of perchloric acid extraction and 31P magnetic resonance spectroscopy at 202.4 MHz. Thirty-one individual phosphorus-containing intermediates of metabolism were identified and quantified for statistical intergroup comparisons. Elevations in relative concentrations of phosphorylethanolamine, IMP, NADP 2'-P, an uncharacterized resonance at 3.72 delta, glycerol 3-phosphorylcholine, phosphorylated glycans and the nucleoside diphosphosugars were seen in malignant tissues concurrently with reductions in relative concentrations of phosphorylcholine, phosphocreatine (PCr), and ATP. The malignant and normal tissue groups were further characterized and contrasted by computing metabolic indices from spectral data. Significant elevations in phosphomonoesters, glycerolphosphodiesters, the ratio of phosphorylethanolamine/phosphorylcholine, and phosphomonoesters/inorganic orthophosphate were detected in malignant tissues along with significant reductions in the ratios of PCr/inorganic orthophosphate, PCr/ATP, the energy charge of the adenylate system and the tissue energy modulus. These results revealed significant alterations in high energy metabolism, low energy metabolism, and membrane metabolism characteristic of malignant tissues. The reduction in high energy phosphates ATP and PCr was balanced by the net increase in nucleoside diphosphosugar and a shift in equilibrium to metabolism involving low energy phosphomonoesters. The spectral data of the tumors, which were of epithelial origin, demonstrated minor metabolites not previously detected in tissue extract analysis of malignant tissues. Detection of these minor metabolites represents an indirect measurement of phospholipid metabolism in malignant tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297695

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Metabolic spectroscopy of inflammation in a bleomycin-induced lung injury model using hyperpolarized 1-(13) C pyruvate.

Authors:  Hoora Shaghaghi; Stephen Kadlecek; Charuhas Deshpande; Sarmad Siddiqui; Daniel Martinez; Mehrdad Pourfathi; Hooman Hamedani; Masaru Ishii; Harrilla Profka; Rahim Rizi
Journal:  NMR Biomed       Date:  2014-05-28       Impact factor: 4.044

2.  Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging.

Authors:  W Mueller-Klieser; S Walenta
Journal:  Histochem J       Date:  1993-06

3.  Phospholipid profiles of human colon cancer using 31P magnetic resonance spectroscopy.

Authors:  T E Merchant; J N Kasimos; P W de Graaf; B D Minsky; L W Gierke; T Glonek
Journal:  Int J Colorectal Dis       Date:  1991-05       Impact factor: 2.571

4.  Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.

Authors:  N R Jagannathan; M Kumar; V Seenu; O Coshic; S N Dwivedi; P K Julka; A Srivastava; G K Rath
Journal:  Br J Cancer       Date:  2001-04-20       Impact factor: 7.640

Review 5.  MRS-based Metabolomics in Cancer Research.

Authors:  Tedros Bezabeh; Omkar B Ijare; Alexander E Nikulin; Rajmund L Somorjai; Ian Cp Smith
Journal:  Magn Reson Insights       Date:  2014-02-13

6.  Metabolic remodeling in human colorectal cancer and surrounding tissues: alterations in regulation of mitochondrial respiration and metabolic fluxes.

Authors:  Vladimir Chekulayev; Kati Mado; Igor Shevchuk; Andre Koit; Andrus Kaldma; Aleksandr Klepinin; Natalja Timohhina; Kersti Tepp; Manana Kandashvili; Lyudmila Ounpuu; Karoliina Heck; Laura Truu; Anu Planken; Vahur Valvere; Tuuli Kaambre
Journal:  Biochem Biophys Rep       Date:  2015-08-29

7.  Metabolic models predict bacterial passengers in colorectal cancer.

Authors:  Annemarie Boleij; Martijn A Huynen; Daniel R Garza; Rahwa Taddese; Jakob Wirbel; Georg Zeller; Bas E Dutilh
Journal:  Cancer Metab       Date:  2020-02-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.